Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis

NCT05947669 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

195

Enrollment

OTHER

Sponsor class

Conditions

Colitis

Interventions

DRUG: Infliximab
DRUG: Methylprednisolone
DRUG: Prednisolone

Sponsor

Odense University Hospital

Collaborators

[object Object]
[object Object]